Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Teladoc, FOLD, Tandem Diabetes Care Inc, Apellis Pharmaceuticals Inc, Wright Medical Group Nv, and represent 23.24% of Sectoral Asset Management's stock portfolio.
- Added to shares of these 10 stocks: Tandem Diabetes Care Inc (+$17.53M), IMMU (+$12.06M), Wright Medical Group Nv (+$11.61M), Inspire Med Sys Inc (+$10.81M), Fibrogen (+$9.33M), Irhythm Technologies Inc Com Added (+$7.79M), Tabula Rasa Healthcare (+$6.63M), Change Healthcare Inc, Aerie Pharmaceuticals, BMRN.
- Started 7 new stock positions in Phasebio Pharmaceuticals Inc, Tabula Rasa Healthcare, Uniqure Nv shs, Homology Medicines Inc, Change Healthcare Inc, IMMU, ALXN.
- Reduced shares in these 10 stocks: , Apellis Pharmaceuticals Inc (-$17.61M), CELG (-$16.95M), ALNY (-$16.62M), Allergan (-$13.48M), GILD (-$11.99M), , , PFE (-$8.47M), Shockwave Med Inc (-$8.27M).
- Sold out of its positions in Abeona Therapeutics, ABMD, Acelrx Pharmaceuticals Inc, Adamas Pharmaceuticals, Aeglea Biotherapeutics, AIS, Anthem, ARRY, BDX, Beigene.
- Sectoral Asset Management was a net seller of stock by $142.19M.
- Sectoral Asset Management has $579.65M in assets under management (AUM), dropping by -30.28%.
Companies in the Sectoral Asset Management portfolio as of September 2019 quarter
Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
---|---|---|---|---|
Teladoc | 6.14 | 525511 | -11% | 67.72 |
Amicus Therapeutics (FOLD) | 4.76 | 3.44M | 8.02 | |
Tandem Diabetes Care Inc | 4.40 | 432815 | +219% | 58.98 |
Apellis Pharmaceuticals Inc | 4.14 | 996983 | -42% | 24.09 |
Wright Medical Group Nv | 3.79 | 1.06M | +112% | 20.63 |
Aerie Pharmaceuticals | 3.62 | 1.09M | +29% | 19.22 |
Shockwave Med Inc | 2.96 | 573434 | -32% | 29.93 |
Inspire Med Sys Inc | 2.77 | 263100 | +206% | 61.02 |
Gilead Sciences (GILD) | 2.70 | 246940 | -43% | 63.38 |
Alnylam Pharmaceuticals (ALNY) | 2.56 | 184341 | -52% | 80.42 |
Portola Pharmaceuticals | 2.53 | 546489 | -10% | 26.82 |
Bristol Myers Squibb (BMY) | 2.45 | 280597 | +28% | 50.71 |
Irhythm Technologies Inc Com Added | 2.40 | 187750 | +127% | 74.11 |
Novartis AG (NVS) | 2.22 | 147846 | -27% | 86.90 |
Ptc Therapeutics I | 2.20 | 377238 | -18% | 33.82 |
Fibrogen | 2.13 | 333460 | +310% | 36.98 |
Immunomedics (IMMU) | 2.08 | 909822 | NEW | 13.26 |
Vocera Communications | 2.04 | 478728 | +25% | 24.65 |
Global Blood Therapeutics In | 2.02 | 241040 | -11% | 48.52 |
Evolent Health | 1.97 | 1.59M | +31% | 7.19 |
AtriCure (ATRC) | 1.93 | 447455 | +13% | 24.94 |
Ra Pharmaceuticals | 1.84 | 451247 | -34% | 23.65 |
Collegium Pharmaceutical Inc Common Stock Usd | 1.79 | 905247 | -3% | 11.48 |
La Jolla Pharmaceuticl Com Par | 1.76 | 1.16M | -34% | 8.80 |
Merck & Co (MRK) | 1.71 | 117600 | -28% | 84.18 |
BioMarin Pharmaceutical (BMRN) | 1.65 | 141801 | +76% | 67.40 |
Cigna Corp New | 1.63 | 62413 | +52% | 151.80 |
Hill-Rom Holdings (HRC) | 1.60 | 88099 | -44% | 105.23 |
Zimmer Holdings (ZMH) | 1.58 | 66598 | +39% | 137.27 |
Boston Scientific Corporation (BSX) | 1.56 | 222176 | -8% | 40.69 |
Acceleron Pharma | 1.55 | 227596 | -15% | 39.51 |
R1 Rcm | 1.52 | 989572 | -8% | 8.93 |
Medtronic | 1.36 | 72651 | -30% | 108.62 |
Abbott Laboratories (ABT) | 1.26 | 87198 | -10% | 83.67 |
D Stemline Therapeutics | 1.22 | 677759 | +13% | 10.41 |
Assembly Biosciences | 1.22 | 719896 | 9.83 | |
Pfizer (PFE) | 1.14 | 183528 | -56% | 35.93 |
Tabula Rasa Healthcare | 1.14 | 120600 | NEW | 54.94 |
Sarepta Therapeutics | 1.10 | 84398 | -34% | 75.32 |
Eli Lilly & Co. (LLY) | 1.08 | 55765 | -49% | 111.83 |
Obseva Sa | 0.92 | 643151 | +2% | 8.33 |
Thermo Fisher Scientific (TMO) | 0.91 | 18200 | +300% | 291.26 |
Forty Seven Inc | 0.90 | 814414 | +74% | 6.42 |
Change Healthcare Inc | 0.85 | 405750 | NEW | 12.08 |
Evelo Biosciences Inc | 0.77 | 732582 | +12% | 6.10 |
Alexion Pharmaceuticals (ALXN) | 0.62 | 36699 | NEW | 97.93 |
Viewray | 0.62 | 1.24M | +10% | 2.90 |
Meiragtx Holdings Plc | 0.56 | 205306 | -36% | 15.95 |
Albireo Pharma | 0.51 | 147211 | -39% | 20.00 |
HMS Holdings (HMSY) | 0.46 | 77725 | -69% | 34.47 |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.41 | 14171 | -30% | 169.43 |
Unum Therapeutics Ord | 0.38 | 1.52M | -4% | 1.44 |
Molecular Templates Inc | 0.33 | 294615 | -15% | 6.59 |
Savara | 0.32 | 710310 | -20% | 2.65 |
Urogen Pharma | 0.27 | 65063 | 23.82 | |
Dr. Reddy's Laboratories (RDY) | 0.26 | 39397 | +100% | 37.90 |
Agios Pharmaceuticals | 0.25 | 45400 | -24% | 32.40 |
Sage Therapeutics | 0.25 | 10500 | -66% | 140.29 |
Homology Medicines Inc | 0.23 | 74381 | NEW | 18.10 |
Uniqure Nv shs | 0.20 | 29500 | NEW | 39.36 |
Spring Bk Pharmaceuticals In | 0.16 | 276656 | 3.44 | |
Allergan | 0.14 | 4800 | -94% | 168.33 |
Phasebio Pharmaceuticals Inc | 0.14 | 196000 | NEW | 4.17 |
Past 13F-HR SEC Filings by Sectoral Asset Management
- Sectoral Asset Management 2019 Q1 filed May 14, 2019
- Sectoral Asset Management 2018 Q4 filed Feb. 12, 2019
- Sectoral Asset Management 2018 Q3 filed Nov. 14, 2018
- Sectoral Asset Management 2018 Q2 filed Aug. 13, 2018
- Sectoral Asset Management 2018 Q1 filed May 15, 2018
- Sectoral Asset Management 2017 Q4 filed Feb. 13, 2018
- Sectoral Asset Management 2017 Q3 filed Nov. 14, 2017
- Sectoral Asset Management 2017 Q2 filed Aug. 14, 2017
- Sectoral Asset Management 2017 Q1 filed May 15, 2017
- Sectoral Asset Management 2016 Q4 filed Feb. 10, 2017
- Sectoral Asset Management 2016 Q3 filed Nov. 10, 2016
- Sectoral Asset Management 2016 Q2 filed Aug. 12, 2016
- Sectoral Asset Management 2016 Q1 filed May 13, 2016
- Sectoral Asset Management 2015 Q4 filed Feb. 12, 2016
- Sectoral Asset Management 2015 Q3 filed Nov. 13, 2015
- Sectoral Asset Management 2015 Q2 filed Aug. 13, 2015
- Sectoral Asset Management 2015 Q1 filed May 14, 2015
- Sectoral Asset Management 2014 Q4 filed Feb. 13, 2015
- Sectoral Asset Management 2014 Q3 filed Nov. 13, 2014